Company profile
LIDDS company profile
LIDDS AB (publ) develops injectable drugs for cancer and other diseases based on our unique proprietary NanoZolid® technology. NanoZolid® helps solve some of the main problems with the way drugs work in the body and which affect patient quality of life. NanoZolid® enables the controlled, long-term and personalized release of drugs for up to six months. NanoZolid® can be combined with traditional small molecules as well as with larger molecules.
Business identity
- Website
- https://liddspharma.com/
- Contact email
- [email protected]
- Phone number
- +46 00 44 55 66
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2003-01-01, Year
Headquarters
- Headquarters
- Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia
- Postal code
- 754 50
- Country code
- RU
- Continent
- Europe